CA2998353A1 — Methods and compositions for soft anticholinergic zwitterions
Assigned to Bodor Laboratories Inc · Expires 2017-03-16 · 9y expired
What this patent protects
Intra-oral formulations comprising soft anticholinergic zwitterions are useful for treating excessive drooling conditions in subjects, such as humans, suffering from sialorrhea. Preferably, at least one soft anticholinergic zwitterion is provided in an effective amount or concent…
USPTO Abstract
Intra-oral formulations comprising soft anticholinergic zwitterions are useful for treating excessive drooling conditions in subjects, such as humans, suffering from sialorrhea. Preferably, at least one soft anticholinergic zwitterion is provided in an effective amount or concentration in an intra-oral formulation that inhibits excessive drooling resulting from a condition known as sialorrhea.
Drugs covered by this patent
- Ecclock (SOFPIRONIUM BROMIDE) · Kaken Pharmaceutical
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.